SEC Form 4 · accession 0001209191-15-086990
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian G. Drazba
Officer — VP, Finance & CFO
Period of report
Dec 22, 2015
Accepted (ET)
Dec 24, 2015 · 12:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 30, 2015 | J | 1,151 | $7.599 | A | 1,969 | D | |
| Common Stock | Oct 30, 2015 | J | 714 | $9.3585 | A | 2,683 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $29.41 | Dec 22, 2015 | A | 50,000 | A | — | Dec 22, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan.
- F2The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.